Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol dose-response with or without dexmedetomidine for hysteroscopy cervical dilation
ChiCTR2000039747Phase 4Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and dexmedetomidine in None (12 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoint: Body movement. Started Nov 2020; status: recruiting.
02
Drugs
propofoldexmedetomidine
Beyond the preview
Go deeper on ChiCTR2000039747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039747.